Search

Displaying results 7821 - 7830 of 10000 in total
  1. Drug

    MDX-1097

    go.drugbank.com/drugs/DB18383
    Experimental

    MDX-1097 is a chimeric monoclonal antibody directed against the kappa myeloma antigen (KMA).

  2. Drug

    Calmangafodipir

    go.drugbank.com/drugs/DB18398
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    FLT201

    go.drugbank.com/drugs/DB18419
    Investigational

    FLT201 is a recombinant adeno-associated viral vector serotype S3 containing codon optimised expression cassette encoding human beta (β)-glucocerebrosidase variant 85 (GCasevar85)

  4. Drug

    ASC-618

    go.drugbank.com/drugs/DB18423
    Investigational

    ASC-618 is a recombinant adeno-associated virus serotype 8 (rAAV2/8) vector expressing bioengineered B domain deleted liver-codon-optimized human factor VIII.

  5. Drug

    Cendakimab

    go.drugbank.com/drugs/DB18427
    Investigational

    Cendakimab is a recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody.

  6. Drug

    AGTC-401

    go.drugbank.com/drugs/DB18432
    Investigational

    AGTC-401 is a recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel beta subunit (rAAV-CNGB3).

    Synonyms: AAV-CNB3, AAV-PR1.7-hCNGBco vector
  7. Drug

    IMMU-114

    go.drugbank.com/drugs/DB18458
    Investigational

    IMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.

  8. Drug

    Eftansomatropin alfa

    go.drugbank.com/drugs/DB18460
    Investigational

    Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment.

  9. Drug

    Esuberaprost

    go.drugbank.com/drugs/DB18464
    Investigational

    Esuberaprost (GP-1681), a drug intended for participants with pulmonary arterial hypertension, was under investigation in clinical trial NCT03657095 to evaluate its efficacy and safety.

  10. Drug

    Spevatamig

    go.drugbank.com/drugs/DB18471
    Investigational

    PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47)